Preparation method and application of sandwich type light addressing immunosensing array with polygon prism structure

By fixing CdSe and nanospheres on polyprism structure Zn/ZnO chips and combining antibody markers, designing sandwich-type photo-addressed immunosensor arrays, the existing photoelectrochemical biosensors have low sensitivity and detection throughput in AD diagnosis. The low problem achieves high sensitivity, fast response, simultaneous detection of Aβ and Tau, reducing detection costs and batch errors.

CN118980723APending Publication Date: 2024-11-19UNIV OF JINAN
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411060175.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-05
Publication Date
2024-11-19

AI Technical Summary

Technical Problem

In AD diagnosis, existing photoelectrochemical biosensors have problems such as low sensitivity, long detection cycle, cumbersome steps, high detection cost, large batch differences, low detection throughput, and single detection objects, making it difficult to achieve high sensitivity and high throughput. Simultaneous detection of Aβ and Tau.

Method used

Sandwich-type light-addressed immune sensing array with polyprism structure is designed to design a sandwich-type light-addressed immune sensing array by fixing CdSe on polyprism structure Zn/ZnO chips and combining ZnFe2O4 nanospheres and antibody markers to achieve the goal of High sensitivity detection of Aβ and Tau.

Benefits of technology

The simultaneous detection of Aβ and Tau with high sensitivity, fast response, simple operation, low cost, small batch differences and high detection throughput is achieved, reducing detection costs and improving detection efficiency and accuracy.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure FT_1
    Figure FT_1
Patent Text Reader

Abstract

The invention relates to a preparation method and application of a sandwich type light addressing immune sensing array with a polygon prism structure, and belongs to the field of photoelectrochemical biosensors. A plurality of working electrodes are integrated in the sensing array, and the manufacturing scheme is as follows: a zinc foil is shaped into a polygon prism structure, ZnO nanorods are directly grown on the surface of the polygon prism structure in situ, Zn / ZnO is sensitized by using CdSe nanospheres, a Zn / ZnO / CdSe polygon prism structure with obviously improved photoelectric activity is obtained, and ZnFe2O4 is used as a detection antibody marker and is used for amplifying signals. By means of a layer-by-layer self-assembly method, Alzheimer's disease AD disease markers such as beta-amyloid protein A beta antibody, microtubule associated protein Tau antibody, bovine serum albumin, Tau antigen, A beta antigen and second antibody marker ZnFe2O4-Ab2 are assembled on a Zn / ZnO / CdSe polygon prism structure, and ultra-sensitive and high-throughput detection of Tau and A beta is achieved by controlling a light source irradiation area.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of photoelectrochemical sensors and relates to a preparation method and application of a sandwich-type light-addressable immunosensor array with a multi-prism structure. Background Art

[0002] AD is the most common dementia to date, accounting for about 80% of all dementia diagnoses. The direct and indirect maintenance costs related to AD are huge each year, posing a challenge to the world's public health system and pension system that cannot be underestimated. Since AD ​​patients do not have obvious symptoms in the early stages, but pathological changes have already occurred. Finding a highly sensitive and high-throughput detection method is conducive to the early diagnosis of AD patients, and timely treatment measures are taken to reduce detection costs and treatment costs. The causes of AD are complex, usually due to abnormal deposition of β-amyloid protein (Aβ) in the brain and the formation of neurofibrillary tangles by phosphorylated Tau protein. Therefore, Aβ and Tau can be used as AD-specific biomarkers. Realizing high-throughput and high-sensitivity detection of Aβ and Tau is of great significance for the prevention and early diagnosis of AD.

[0003] There are many methods for diagnosing and monitoring neurodegenerative diseases, such as cerebrospinal fluid analysis, genetic testing, blood testing, etc. It should be noted that these measurement techniques are affected by many factors and have disadvantages such as low sensitivity, long detection cycle, cumbersome steps, and high detection cost. Photoelectrochemical biosensors combine the dual advantages of electrochemistry and photoelectrochemistry. Compared with other detection methods, they have the advantages of high sensitivity, rapid response, simple operation, and low cost. However, they also have limitations such as large batch differences, low detection flux, and single detection object. In order to overcome the above shortcomings of photoelectrochemical biosensors, the present invention utilizes a photoelectrochemical biosensor array with small batch differences, high detection flux, and the ability to simultaneously detect Aβ and Tau. Summary of the invention

[0004] The purpose of the present invention is to avoid the shortcomings of traditional detection methods such as low sensitivity, long detection cycle, complicated steps, and high detection cost, and provide a preparation method and application of a sandwich-type light-addressable immunosensor array with a polygonal prism structure that has high sensitivity, rapid response, simple operation, low cost, small batch difference, high detection flux, and can simultaneously detect Aβ and Tau.

[0005] 1. A method for preparing a sandwich-type light-addressable immunosensor array with a multi-prism structure, characterized in that it comprises the following steps: 1. Preparation of polyhedral Zn / ZnO sheets; 2. Fix CdSe on a Zn / ZnO sheet with a polygonal prism structure; 3. Preparation of sandwich-type light-addressable immunosensor array; Among them, the specific steps of step 1 for preparing a polyhedral Zn / ZnO sheet are: (1) A zinc foil with a purity of 99.99% was polished and ground with 1500-mesh and 2000-mesh sandpapers, and the polished zinc foil was folded into a three- to eight-sided prism structure in equal proportions, ultrasonically cleaned in ethanol and deionized water for 10 to 20 minutes, respectively, and then dried with nitrogen; (2) preparing 35-70 mL of an aqueous solution of 0.3-0.6 mol / L NH3·H2O and 0.06-0.12 mol / L NaOH, ultrasonicating for 10-20 min, transferring the solution and the cleaned polyhedral prism structure in step (1) into a 50-100 mL polytetrafluoroethylene-lined autoclave, heating the reaction at 100°C for 44-48 h, and naturally cooling to room temperature to obtain a polyhedral prism Zn / ZnO sheet, taking it out of the solution, rinsing it with deionized water and ethanol, and vacuum drying it at 60°C; Among them, the specific steps of step 2 for fixing CdSe on the polyhedral Zn / ZnO sheet are: (1) Prepare 35-70 mL of an aqueous solution of 0.2 mol / L Na2SO3, 0.1 mol / L Se and 0.05 mol / L NaOH, ultrasonicate for 1-1.5 h, slowly transfer the solution to a 50-100 mL polytetrafluoroethylene-lined autoclave, heat at 70 °C for 6-8 h to obtain a modified Na2SeSO3 solution, and then filter the modified Na2SeSO3 solution with a 0.22 μm filter syringe and store at 60 °C in the dark. (2) Add 30-60 mL ultrapure water and 7-14 mL of the modified Na2SeSO3 solution obtained in step (1) to a brown frosted glass stopper flask, ultrasonicate for 10-20 min, then add 0.02-0.04 mol / L Cd(CH3COO)2·2H2O, ultrasonicate for 10-20 min, continue to add 0.6 mol / L NH3H2O, ultrasonicate for 10-20 min, transfer the above solution to a 100-150 mL polytetrafluoroethylene-lined autoclave, and slowly immerse the polyhedral Zn / ZnO sheet obtained in step 1 into the solution, heat at 90°C for reaction for 1-1.5 h, and after the reaction is completed, remove the product from the mixed solution, rinse thoroughly with deionized water and ethanol, respectively, and vacuum dry at 60°C to obtain a polyhedral Zn / ZnO / CdSe sheet; Among them, the specific steps of preparing the sandwich-type light-addressable immunosensor array in step three are: (1) 2 ~ 4 mmol ZnCl2·6H2O and 4 ~ 8 mmol FeCl3·6H2O were dissolved in 30 ~ 60 mL ethylene glycol, and then 30 ~ 70 mmol sodium acetate was slowly added. The mixture was ultrasonicated for 1 ~ 1.5 h, and the solution was slowly transferred to a 50 ~ 100 mL polytetrafluoroethylene-lined autoclave. The reaction was heated at 180 °C for 17 ~ 20 h. The obtained product was washed by centrifugation with ethanol and ultrapure water for 3 times each, and vacuum dried at 60 °C for 12 h. Finally, the dried product was reacted in a tube furnace at 500 °C in an argon environment for 2 hours to obtain ZnFe2O4 nanospheres. (2) Dissolve 5-10 mg ZnFe2O4 nanospheres in 5-10 mL 1 mol / L sodium tartrate solution, incubate in an oil bath at 80°C for 10-12 h, wash by centrifugation, and redisperse in 5-10 mL ultrapure water. Then add 8-16 mL 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide / N-hydroxysuccinimide to the above solution and activate by shaking for 1-2 h. After activation, wash by centrifugation, and redisperse in 5-10 mL PBS buffer solution. Then add 1-2 mL secondary antibody Ab2 (10 μg mL -1 ), incubate at 4°C with shaking for 1 to 2 h, centrifuge after the incubation and wash with PBS buffer solution, redisperse in 5 to 10 mL PBS buffer solution, finally add 1 to 2 mL of 1% bovine serum albumin PBS buffer solution to the above solution, incubate at 4°C with shaking for 1 to 2 h to block non-specific binding sites, centrifuge after the incubation and wash and disperse in 5 to 10 mL PBS buffer solution to obtain ZnFe2O4-Ab2 solution; the secondary antibody can be a secondary antibody for β-amyloid protein Aβ or microtubule-associated protein Tau; (3) Paste 1 to 20 pieces of insulating stickers with a side length of 2 to 5 mm and a circular hollow with a diameter of 1 to 4 mm in the center on each side of the multi-prism structure Zn / ZnO / CdSe sheet obtained in step 2, so that each side of the working electrode is divided into 1 to 20 circular points of the same size; (4) Modify each of the above sites with 3 to 4 µL of 0.1 mol / L thioglycolic acid, dry at room temperature, and continue to add 3 to 4 μL of 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide / N-hydroxysuccinimide. After reacting for 20 to 40 min, rinse with ultrapure water and dry naturally. (5) The electrode surface obtained in step (4) is modified with 4 to 5 µL, 8 to 10 µg / mL of primary antibody Ab1, reacted for 20 to 40 min, rinsed with ultrapure water, and dried naturally; the primary antibody can be the primary antibody of Aβ or Tau; (6) The electrode surface sites obtained in step (5) were modified with 4 to 5 µL of 1 to 1.5% bovine serum albumin solution to block nonspecific active sites on the electrode surface. After reacting for 20 to 40 min, the electrode was rinsed with ultrapure water and dried naturally. (7) Modify the electrode surface points obtained in step (6) with 4 to 5 µL of antigen or sample solution, react for 20 to 40 min, rinse with ultrapure water, and dry naturally; (8) The electrode surface sites obtained in step (7) were modified with 4 to 5 µL of ZnFe2O4-Ab2 obtained in step (2), and after reacting for 20 to 40 min, the mixture was rinsed with ultrapure water and dried naturally to obtain a sandwich-type light-addressable immunosensor array.

[0006] 2. The prepared multi-prism structure sandwich light-addressable immunosensor array is characterized in that it is used for Aβ and Tau detection, and the application steps are as follows: (1) Preparation of standard solutions: Prepare a set of standard solutions of Aβ antigen and Tau antigen with different concentrations including blank standards; (2) Working electrode modification: blank standard sample and Aβ and Tau antigen standard solutions of different concentrations were applied to step 3 (7) of technical solution 1, and the rest remained unchanged as the working electrode; (3) Working curve drawing: A saturated calomel electrode is used as the reference electrode, a platinum wire electrode is used as the auxiliary electrode, and a three-electrode system is formed with the working electrode modified in step (2) and tested in an electrolyte solution; the analyte is detected using the It curve, the voltage is set to 0 V, the running time is 100 s, and the excitation light source is an LED lamp; the photocurrent intensity generated by different concentrations of Aβ antigen standard solutions and different concentrations of Tau antigen standard solutions is detected, and a working curve is drawn; the photocurrent intensity of the calibration area with a blank standard sample is recorded as I 0, the photocurrent intensity of the standard solution containing different concentrations of Aβ antigen is recorded as I a ,make I 1= I a - I 0, I 1 and Aβ antigen standard solution c There is a linear relationship between the logarithms of 1, and the I 1 – lg c1 Working curve; The photocurrent intensity of the standard solution containing different concentrations of Tau antigen is recorded as I t ,make I 2= I t - I 0, I 2 and Tau antigen standard solution c There is a linear relationship between the logarithms of 2, and the I 2 – lg c 2 working curve; (4) Detection of Aβ and Tau: Replace the antigen standard solution in step (2) with the human serum sample to be tested, and keep the other parameters unchanged. Perform the detection according to the method in steps (2) and (3). I 1 、I 2 and the working curve to obtain the content of Aβ and Tau in the sample to be tested.

[0007] (1) The present invention achieves the purpose of multi-point continuous detection by rotating and moving the working electrode of the multi-prism structure to divide the detection points into multiple positions, thereby reducing the detection cost and batch error and improving the detection efficiency and accuracy.

[0008] (2) The present invention directly grows ZnO nanorods in situ on zinc foil, uses CdSe to sensitize Zn / ZnO, and obtains a Zn / ZnO / CdSe polyhedral structure with significantly improved photoelectric activity. ZnFe2O4 is used as a detection antibody marker to compete with Zn / ZnO / CdSe to consume electron donors, amplify the signal, and improve the sensitivity of the sensor.

[0009] (3) The present invention can simultaneously detect Aβ and Tau in complex samples at one time with good accuracy and precision. BRIEF DESCRIPTION OF THE DRAWINGS

[0010] Figure 1 This is a schematic diagram of the three-electrode system. a is the Zn / ZnO / CdSe multi-prism structure, b is the insulating sticker, c and d are the detection point arrays, e is the calibration area, f is the reference electrode, g is the auxiliary electrode, h is the electrolyte solution, i is the excitation light source, and j is the electrolytic cell. DETAILED DESCRIPTION

[0011] The present invention is further described below with reference to the accompanying drawings and embodiments.

[0012] Embodiment 1 The method for preparing a sandwich-type light-addressable immunosensor array with a multi-prism structure according to the present invention is combined with Figure 1 , the steps are as follows.

[0013] In the first step, the zinc foil was polished and then folded into a four-sided prism structure in equal proportion, and then dried with nitrogen. 35 mL of an aqueous solution of 0.3 mol / L NH3·H2O and 0.06 mol / L NaOH was prepared, and the solution and the dried prism-shaped zinc foil were transferred to a 50 mL polytetrafluoroethylene-lined autoclave, and heated at 100 °C for 44 h to obtain a Zn / ZnO prism structure, which was then cleaned and dried. In the second step, 35 mL of an aqueous solution of 0.2 mol / L Na2SO3, 0.1 mol / L Se, and 0.05 mol / L NaOH was prepared. The above solution was slowly transferred to a 50 mL polytetrafluoroethylene-lined autoclave and heated at 70 °C for 6 h to obtain a modified Na2SeSO3 solution. The modified Na2SeSO3 solution was then filtered with a 0.22 μm filter syringe and stored at 60 °C in the dark. 30 mL of ultrapure water and 7 mL of the modified Na2SeSO3 solution were added to a brown frosted glass stopper flask. 0.02 mol / L Cd(CH3COO)2·2H2O was added to the above Na2SeSO3 solution. 0.6 M NH3 H2O was added to the above mixed solution. The above solution was transferred to a 100 mL polytetrafluoroethylene-lined autoclave, and the Zn / ZnO polygonal prism structure obtained in the first step was slowly immersed in the solution, and heated at 90 °C for 1 h to obtain a Zn / ZnO / CdSe tetrahedral prism structure a. The third step is to dissolve 2 mmol ZnCl2·6H2O and 4 mmol FeCl3·6H2O in 30 mL ethylene glycol, and then slowly add 30 mmol sodium acetate. The above solution is slowly transferred to a 50-100 mL polytetrafluoroethylene-lined autoclave, heated at 180 °C for 17 h, centrifuged and washed, and finally the dried product is reacted in a tube furnace at 500 °C in an argon environment for 2 h to obtain ZnFe2O4 nanospheres; In the fourth step, 5 mg of ZnFe2O4 nanospheres were dissolved in 5 mL of 1 mol / L sodium tartrate solution, incubated in an oil bath at 80 °C for 10 h, and then centrifuged and washed and redispersed in 5 mL of ultrapure water. 8 mL of 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide / N-hydroxysuccinimide was added to the above solution, and the mixture was activated by shaking for 1 h. After activation, the mixture was centrifuged and washed and redispersed in 5 mL of PBS buffer solution. 1 mL of secondary antibody Ab2 (10 μg mL -1), incubated at 4°C for 1 h, centrifuged and washed with PBS buffer solution after the incubation, and redispersed in 5 mL PBS buffer solution. Finally, 1 mL of 1% bovine serum albumin PBS buffer solution was added to the above solution, incubated at 4°C for 1 h to block non-specific binding sites, centrifuged and washed after the incubation, and dispersed in 5 mL PBS buffer solution to obtain ZnFe2O4-Ab2 solution; the secondary antibody can be a secondary antibody for amyloid β protein Aβ or microtubule-associated protein Tau; Step 5: 8 pieces of insulating stickers b with a side length of 5 mm and a circular hollow with a diameter of 4 mm in the center are pasted on each side of the Zn / ZnO / CdSe tetrahedral prism structure a obtained in the second step, so that each side of the working electrode is divided into 8 circular points of the same size; Step 6: Modify each point with 3 µL of 0.1 mol / L thioglycolic acid, dry at room temperature, and continue to drop 4 µL of 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide / N-hydroxysuccinimide, react for 20 min, rinse with ultrapure water, and dry naturally; modify the electrode surface point c and the opposite point with 4 µL of primary antibody Ab1 at 8 µg / mL, react for 20 min, rinse with ultrapure water, and dry naturally; modify the electrode surface points with 4 µL of 1% bovine serum albumin solution, react for 20 min, rinse with ultrapure water, and dry naturally; the primary antibody can be the first antibody of Aβ or Tau; leave an edge point e on the electrode surface as a calibration area, modify the point opposite to the electrode surface point c with 4 µL of Aβ antigen with increasing concentration gradient, react for 20 min, rinse with ultrapure water, and dry naturally; modify the point opposite to the electrode surface point d with 4 µL of Tau antigen in a gradient of concentrations was added in sequence, and the reaction lasted for 20 min before rinsing with ultrapure water and naturally drying; 4 µL of ZnFe2O4-Ab2 was modified at other points in the non-calibration area e, and the reaction lasted for 20 min before rinsing with ultrapure water and naturally drying to obtain a self-calibrated photoelectrochemical Aβ and Tau sensor array.

[0014] Embodiment 2 The concentrations of NH3·H2O and NaOH were changed to 0.6 mol / L and 0.12 mol / L, respectively. The other conditions were the same as those in Example 1.

[0015] Embodiment 3 The amount of antibody applied on the working electrode surface was changed to 4 μL, and the rest was the same as in Example 1.

[0016] Embodiment 4 The concentration of the antibody coated on the working electrode surface was changed to 8 µg / mL, and the rest was the same as in Example 1.

[0017] Embodiment 5 The sandwich-type light-addressable immunosensor arrays with polygonal prism structures prepared in Examples 1 to 4 are used for the detection of Aβ and Tau, and the steps are as follows.

[0018] (1) Preparation of standard solutions: Prepare a set of standard solutions of Aβ antigen and Tau antigen with different concentrations including blank standards; (2) Working electrode modification: blank standard sample and different concentrations of Aβ and Tau antigen standard solutions were dropped onto other points except calibration point e, and the others remained unchanged as working electrodes; (3) Working curve drawing: A saturated calomel electrode is used as the reference electrode, a platinum wire electrode is used as the auxiliary electrode, and a three-electrode system is formed with the working electrode modified in step (2) and tested in an electrolyte solution; the analyte is detected using the It curve, the voltage is set to 0 V, the running time is 100 s, and the excitation light source is an LED lamp; the photocurrent intensity generated by different concentrations of Aβ antigen standard solutions and different concentrations of Tau antigen standard solutions is detected, and a working curve is drawn; the photocurrent intensity of the calibration area with a blank standard sample is recorded as I 0, the photocurrent intensity of the standard solution containing different concentrations of Aβ antigen is recorded as I a ,make I 1= I a - I 0, I 1 and Aβ antigen standard solution c There is a linear relationship between the logarithms of 1, and the I 1 – lg c 1 Working curve; The photocurrent intensity of the standard solution containing different concentrations of Tau antigen is recorded as I t ,make I 2= I t - I 0, I 2 and Tau antigen standard solution c There is a linear relationship between the logarithms of 2, and the I 2 – lg c 2 working curve; (4) Detection of Aβ and Tau: Replace the antigen standard solution in step (2) with the human serum sample to be tested, and keep the other parameters unchanged. Perform the detection according to the method in steps (2) and (3). I 1 、I 2 and the working curve to obtain the content of Aβ and Tau in the sample to be tested.

Claims

1. A method for preparing a sandwich-type light-addressable immunosensor array with a multi-prism structure, characterized in that: The following steps are involved:

1. Preparation of polyhedral Zn / ZnO sheets; 2. Fix CdSe on a Zn / ZnO sheet with a polygonal prism structure; 3. Preparation of sandwich-type light-addressable immunosensor array; Among them, the specific steps of step 1 for preparing a polyhedral Zn / ZnO sheet are: (1) A zinc foil with a purity of 99.99% was polished and ground with 1500-mesh and 2000-mesh sandpapers, and the polished zinc foil was folded into a three- to eight-sided prism structure in equal proportions, ultrasonically cleaned in ethanol and deionized water for 10 to 20 min, respectively, and then dried with nitrogen; (2) preparing 35-70 mL of an aqueous solution of 0.3-0.6 mol / L NH3·H2O and 0.06-0.12 mol / L NaOH, ultrasonicating for 10-20 min, transferring the solution and the cleaned polyhedral prism structure in step (1) into a 50-100 mL polytetrafluoroethylene-lined autoclave, heating the reaction at 100°C for 44-48 h, and naturally cooling to room temperature to obtain a polyhedral prism Zn / ZnO sheet, taking it out of the solution, rinsing it with deionized water and ethanol, and vacuum drying it at 60°C; Among them, the specific steps of step 2 for fixing CdSe on the polyhedral Zn / ZnO sheet are: (1) Prepare 35-70 mL of an aqueous solution of 0.2 mol / L Na2SO3, 0.1 mol / L Se and 0.05 mol / L NaOH, ultrasonicate for 1-1.5 h, slowly transfer the solution to a 50-100 mL polytetrafluoroethylene-lined autoclave, heat at 70 °C for 6-8 h to obtain a modified Na2SeSO3 solution, and then filter the modified Na2SeSO3 solution with a 0.22 μm filter syringe and store at 60 °C in the dark. (2) Add 30-60 mL ultrapure water and 7-14 mL of the modified Na2SeSO3 solution obtained in step (1) to a brown frosted glass stopper flask, ultrasonicate for 10-20 min, then add 0.02-0.04 mol / L Cd(CH3COO)2·2H2O, ultrasonicate for 10-20 min, continue to add 0.6 mol / L NH3H2O, ultrasonicate for 10-20 min, transfer the above solution to a 100-150 mL polytetrafluoroethylene-lined autoclave, and slowly immerse the polyhedral Zn / ZnO sheet obtained in step 1 into the solution, heat at 90°C for reaction for 1-1.5 h, and after the reaction is completed, remove the product from the mixed solution, rinse thoroughly with deionized water and ethanol, respectively, and vacuum dry at 60°C to obtain a polyhedral Zn / ZnO / CdSe sheet; Among them, the specific steps of preparing the sandwich-type light-addressable immunosensor array in step three are: (1) 2 ~ 4 mmol ZnCl2·6H2O and 4 ~ 8 mmol FeCl3·6H2O were dissolved in 30 ~ 60 mL ethylene glycol, and then 30 ~ 70 mmol sodium acetate was slowly added. The mixture was ultrasonicated for 1 ~ 1.5 h, and the solution was slowly transferred to a 50 ~ 100 mL polytetrafluoroethylene-lined autoclave. The autoclave was heated at 180 °C for 17 ~ 20 h. The obtained product was washed by centrifugation with ethanol and ultrapure water for 3 times each, and vacuum dried at 60 °C for 12 h. Finally, the dried product was reacted in a tube furnace at 500 °C in an argon environment for 2 hours to obtain ZnFe2O4 nanospheres. (2) Dissolve 5-10 mg ZnFe2O4 nanospheres in 5-10 mL 1 mol / L sodium tartrate solution, incubate in an oil bath at 80 °C for 10-12 h, wash by centrifugation, and redisperse in 5-10 mL ultrapure water. Then add 8-16 mL 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide / N-hydroxysuccinimide to the above solution and activate by shaking for 1-2 h. After activation, wash by centrifugation, and redisperse in 5-10 mL PBS buffer solution. Then add 1-2 mL secondary antibody Ab2 (10 μg mL -1 ), incubate at 4°C with shaking for 1 to 2 h, centrifuge after the incubation and wash with PBS buffer solution, redisperse in 5 to 10 mL PBS buffer solution, finally add 1 to 2 mL of 1% bovine serum albumin PBS buffer solution to the above solution, incubate at 4°C with shaking for 1 to 2 h to block non-specific binding sites, centrifuge after the incubation and wash and disperse in 5 to 10 mL PBS buffer solution to obtain ZnFe2O4-Ab2 solution; the secondary antibody can be a secondary antibody for amyloid β protein Aβ or microtubule-associated protein Tau; (3) Paste 1 to 20 pieces of insulating stickers with a side length of 2 to 5 mm and a circular hollow with a diameter of 1 to 4 mm in the center on each side of the multi-prism structure Zn / ZnO / CdSe sheet obtained in step 2, so that each side of the working electrode is divided into 1 to 20 circular points of the same size; (4) Modify each of the above-mentioned sites with 3 to 4 µL of 0.1 mol / L thioglycolic acid, dry at room temperature, and continue to drop 3 to 4 μL of 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide / N-hydroxysuccinimide. After reacting for 20 to 40 min, rinse with ultrapure water and dry naturally. (5) The electrode surface obtained in step (4) is modified with 4 to 5 µL, 8 to 10 µg / mL of primary antibody Ab1, reacted for 20 to 40 min, rinsed with ultrapure water, and dried naturally; the primary antibody can be the primary antibody of Aβ or Tau; (6) The electrode surface sites obtained in step (5) were modified with 4 to 5 µL of 1 to 1.5% bovine serum albumin solution to block nonspecific active sites on the electrode surface. After reacting for 20 to 40 min, the electrode was rinsed with ultrapure water and dried naturally. (7) Modify the electrode surface points obtained in step (6) with 4 to 5 µL of antigen or sample solution, react for 20 to 40 min, rinse with ultrapure water, and dry naturally; (8) The electrode surface sites obtained in step (7) were modified with 4 to 5 µL of ZnFe2O4-Ab2 obtained in step (2), and after reacting for 20 to 40 min, the mixture was rinsed with ultrapure water and dried naturally to obtain a sandwich-type light-addressable immunosensor array.

2. The prepared sandwich-type light-addressable immunosensor array with a multi-prism structure is characterized in that: For Aβ and Tau detection, the application steps are as follows: (1) Preparation of standard solutions: Prepare a set of standard solutions of Aβ antigen and Tau antigen with different concentrations including blank standards; (2) Working electrode modification: a blank standard sample and standard solutions of Aβ and Tau antigens of different concentrations are applied to step 3 (7) of claim 1, and the rest remain unchanged as the working electrode; (3) Working curve drawing: A saturated calomel electrode is used as the reference electrode, a platinum wire electrode is used as the auxiliary electrode, and a three-electrode system is formed with the working electrode modified in step (2) and tested in an electrolyte solution; the analyte is detected using the It curve, the voltage is set to 0 V, the running time is 100 s, and the excitation light source is an LED lamp; the photocurrent intensity generated by different concentrations of Aβ antigen standard solutions and different concentrations of Tau antigen standard solutions is detected, and a working curve is drawn; the photocurrent intensity of the calibration area with a blank standard sample is recorded as I 0, the photocurrent intensity of the standard solution containing different concentrations of Aβ antigen is recorded as I a ,make I 1= I a - I 0, I 1 and Aβ antigen standard solution c There is a linear relationship between the logarithms of 1, and the I 1 – lg c 1 Working curve; The photocurrent intensity of the standard solution containing different concentrations of Tau antigen is recorded as I t ,make I 2= I t - I 0, I 2 and Tau antigen standard solution c There is a linear relationship between the logarithms of 2, and the I 2 – lg c 2 working curve; (4) Detection of Aβ and Tau: Replace the antigen standard solution in step (2) with the human serum sample to be tested, and keep the other parameters unchanged. Perform the detection according to the method in steps (2) and (3). I 1 、I 2 and the working curve to obtain the content of Aβ and Tau in the sample to be tested.